Skip to main content
. 2017 Nov 3;8(63):107295–107302. doi: 10.18632/oncotarget.22364

Table 1. The main characteristics of the included studies.

HBV and NAFLD
Study/Years of Publication Country HBV+/HBV- Follow Sources of Controls Outcome Subtype of study Exposure Adjusted Factors Adjusted OR/RR (95% CI)
Vincent Wai-Sun Wong.2012 Hong Kong 91/922 2008-2010 population NAFLD cross-sectional HBV alcohol consumption, demographic, and metabolic factors 0.42 (0.20, 0.88)
Yuan-Lung Cheng.2013 Taiwan 3642/29797 2002-2009 hospital NAFLD cross-sectional HBV age, sex, BMI,WC,SBP, fasting glucose, cholesterol, LDL, TG, ALT, GGT, platelet counts, FLI 0.66 (0.59, 0.72)
Eun-Jeong Joo.2016 Korea 3926/79413 2002-2014 population NAFLD cohort HBV age, sex, year of visit, smoking status, alcohol intake, regular exercise, education level, and body mass index 0.83 (0.73, 0.94)
Chia-Chi Wang.2007 Taiwan 50/457 NR hospital NAFLD case-control HBV age, sex, ALT, riglyceride, total cholesterol, Body mass index, fasting blood glucose 0.97 (0.48, 1.95)
Peng XE.2013 China 527/1042 2007-2008 hospital NAFLD cross-sectional HBV NR 3.96 (2.10, 7.48)

RR, relative risk. OR, odds ratio. CI, confidence interval. NAFLD, nonalcoholic fatty liver disease. NR, no report. BMI, body mass index. WC, waist circumference. SBP, systolic blood pressure. HDL, high-density lipoprotein. LDL, low-density lipoprotein. TG, triglyceride. ALT, alanine aminotransferase. GGT, gamma-glutamyltransferase.